Open Biosystems

Thermo Fisher Scientific this week announced that it will acquire Life Technologies for $13.6 billion in a deal that will bring together two of the largest providers of RNAi research products into a single entity.

While few details about the plaintiff in the case, PSN Illinois, were available, court filings indicate that the company has initiated numerous and varied patent-infringement suits in recent years.

According to Whitehead, Alnylam and Max Planck's request to block the case represents an "eleventh hour … rush into court to seek emergency relief from a situation of their own making," and should therefore be denied.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.